New options for second-line therapy of advanced renal cancer.
作者信息
Bex Axel
机构信息
The Netherlands Cancer Institute, Division of Surgical Oncology-Urology, Plesmanlaan 121, 1066 CX Amsterdam, Netherland.
出版信息
Lancet Oncol. 2013 May;14(6):450-1. doi: 10.1016/S1470-2045(13)70119-0. Epub 2013 Apr 16.
Abstract
摘要
Zotero 插件